CSF1R and Miyoshi myopathy: Although it is not known whether targeting CSF1R shows selective suppression against M-MDSCs in vivo, this study shows a possible strategy for overcoming M-MDSC-mediated reduction of melphalan effect in MM patients undergoing ASCT.